A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2002
12/17/2002	US6495565 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition
12/17/2002	US6495560 10,11-dihydro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-1 -ethoxy)-5h-dibenzo(a,d)cycloheptene-10-acetic acid; treatment of osteoporosis
12/17/2002	US6495559 For therapy of obesity
12/17/2002	US6495556 Treating leukemia and lymphoma, sunburn and skin cancer
12/17/2002	US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid.
12/17/2002	US6495544 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase
12/17/2002	US6495543 Treating or preventing melatoninergic disorders
12/17/2002	US6495537 Method for inhibition of photocarcinogenesis or photoimmunosuppression using niacin
12/17/2002	US6495525 N-((4-(((2-methylphenylamino)carbonyl)amino)phenyl)acetyl)-l -prolyl-3-methyl)-beta-alanine; very late antigen-4 cell adhesion inhibitor; inflammation and immune reactions
12/17/2002	US6495522 Substituted alpha-hydroxy acid caspase inhibitors and the use thereof
12/17/2002	US6495519 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
12/17/2002	US6495516 Method for killing gram-negative bacteria with biologically active peptides from functional domains of bacterial/permeability-increasing protein
12/17/2002	US6495347 Determining if fusion protein stimulates a th1-like response in cell sample; fusion proteins and conjugates that contain at least a portion of a heat shock protein; response detected by measuring interferon (ifn)-gamma produced by the cell sample
12/17/2002	US6495346 Do not react with foreign partners; amino acids inserted into proteins which naturally form dimers, mutated proteins only form complexes with themselves (homodimers) or with the mutated partner (heterodimers), not with nonmutated starting
12/17/2002	US6495171 Interleukin-4 production inhibitors
12/17/2002	US6495128 Human chemokine β-7 deletion and substitution proteins
12/17/2002	CA2132636C Rapamycin formulation for iv injection
12/17/2002	CA2063106C Ciclosporin form for pulmonary administration
12/17/2002	CA2061675C Quinoline-containing ketoacids as leukotriene antagonists
12/17/2002	CA2037408C A nonaqueous pharmaceutical macrolide solution
12/16/2002	WO2002083633A1 Suplatast tosilate crystals
12/12/2002	WO2002099115A2 Nucleic acid-associated proteins
12/12/2002	WO2002099108A2 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002	WO2002099101A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
12/12/2002	WO2002099035A2 Chimeric alphavirus replicon particles
12/12/2002	WO2002098907A2 Cation conducting gabaa receptors and their use
12/12/2002	WO2002098880A1 5-ethyl-imidazotriazinones
12/12/2002	WO2002098879A1 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases
12/12/2002	WO2002098878A1 Trifluoromethylpurines as phosphodiesterase 4 inhibitors
12/12/2002	WO2002098875A1 Carboline derivatives as pde-5 inhibitors
12/12/2002	WO2002098873A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	WO2002098869A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds
12/12/2002	WO2002098840A1 Carboxylic acid derivative and medicine comprising salt or ester of the same
12/12/2002	WO2002098482A2 System for osmotic delivery of pharmaceutically active agents
12/12/2002	WO2002098459A2 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS
12/12/2002	WO2002098450A1 Altering an immune response by influencing the interaction of lair with its ligand
12/12/2002	WO2002098438A1 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use
12/12/2002	WO2002098437A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof
12/12/2002	WO2002098431A1 Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
12/12/2002	WO2002098428A1 Tetracyclic compounds as pde5-inhibitors
12/12/2002	WO2002098426A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases
12/12/2002	WO2002098424A1 Novel anti-infectives
12/12/2002	WO2002098422A1 Use of methylnaltrexone to treat immune suppression
12/12/2002	WO2002098397A2 Therapeutic compositions for modulating the immune response in a mammal and use thereof
12/12/2002	WO2002098370A2 Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
12/12/2002	WO2002098363A2 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM
12/12/2002	WO2002083879A3 Immunotherapy based on dendritic cells
12/12/2002	WO2002076494A3 USE OF CYTOKINES OF THE TGF-β SUPERFAMILY FOR THE TREATMENT AND DIAGNOSIS OF SKIN RELATED DISORDERS
12/12/2002	WO2002074798A3 The genome of a bifidobacterium
12/12/2002	WO2002072548A3 Heterocyclic compounds and their use as histamine h4 ligands.
12/12/2002	WO2002067848A3 PEPTIDES FROM THE 16/6id ANTIBODY FOR TREATING SLE
12/12/2002	WO2002066458A3 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
12/12/2002	WO2002064591A3 Carboline derivatives
12/12/2002	WO2002064161A3 Method and compositions for immunization with the pseudomonas v antigen
12/12/2002	WO2002062792A9 Jnk inhibitor
12/12/2002	WO2002053288A3 A method for the manufacture of compositions containing low concentrations of salts
12/12/2002	WO2002029044A3 Modulation of the transcription of pro-inflammatory gene products
12/12/2002	WO2002018593A3 Modulation of fas and fasl expression
12/12/2002	WO2002018557A3 Human kinases
12/12/2002	WO2002004424A9 Pyrazole derivatives
12/12/2002	WO2002004017A3 Method for preparing oral vaccines
12/12/2002	WO2001095922A1 Remedies for allergic diseases and process for producing the same
12/12/2002	US20020188142 17-Side chain alkynyl-and 20-oxopregna-derivatives of vitamin D, methods for their production and pharmaceutical compositions thereof
12/12/2002	US20020188134 Pharmaceutical compositions
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002	US20020188107 Plant protein for use in the treatment of cancer
12/12/2002	US20020188100 Boron compound for use in the treatment of stroke, heart defects, inflammation, autoimmune and cancer disease
12/12/2002	US20020188018 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/12/2002	US20020188009 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
12/12/2002	US20020187999 Anti-inflammatory uses of manzamines
12/12/2002	US20020187989 Preventive or therapeutic drugs for various eosinophilia-related diseases containg chymase inhibitors as the active ingredient
12/12/2002	US20020187978 4-Heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
12/12/2002	US20020187939 Use of inhibitors of the renin-angiotensin system
12/12/2002	US20020187934 Peptide derivatives
12/12/2002	US20020187930 Substances and their uses
12/12/2002	US20020187535 Enzymatic polypeptide for use in the treatment of emphysema, adult respiratory distress syndrome and psoriasis
12/12/2002	US20020187523 Extracellular signaling molecules
12/12/2002	US20020187492 Nucleotide sequences coding polypeptides for use in the treatnment of inflammation
12/12/2002	US20020187163 Herpes simplex virus comprising a mutation within the BstEII-EcoNI fragment of the BamHI x fragment of said virus; cancer vaccine
12/12/2002	US20020187160 Vaccine delivery system
12/12/2002	US20020187159 The use of heat shock protein 70 preparations in vaccination against cancer and infectious disease
12/12/2002	US20020187158 An allergenic protein which derivative has a reduced allergenic activity compared with the allergenic protein from which it is derived, e.g., Bet v 1, for the treatment or prevention of an allergic disorder
12/12/2002	US20020187156 Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
12/12/2002	US20020187148 T cell receptor ligands and methods of using same
12/12/2002	US20020187145 Lysing or blocking unwanted cells with IL-2 receptor-specific binding substance
12/12/2002	US20020187135 Methods for inducing antigen-specific t cell tolerance
12/12/2002	CA2830887A1 Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
12/12/2002	CA2449843A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use, and processes for preparing them
12/12/2002	CA2449770A1 Novel anti-infectives
12/12/2002	CA2449175A1 Use of methylnaltrexone to treat immune suppression
12/12/2002	CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	CA2449097A1 5-ethyl-imidazotriazinones
12/12/2002	CA2449095A1 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases
12/12/2002	CA2449024A1 Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
12/12/2002	CA2448606A1 Nucleic acid-associated proteins
12/12/2002	CA2448444A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
12/12/2002	CA2448066A1 Chimeric alphavirus replicon particles
12/12/2002	CA2448044A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof
12/12/2002	CA2447935A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
12/12/2002	CA2445460A1 Carboline derivatives as pde-5 inhibitors

1 ... 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 ... 1172